CEBPA Double Mutation
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Efficacy of HAD Induction With Intensified Cytarabine in Newly-diagnosed CEBPA Double Mutated Acute Myeloid Leukemia (NCT04415008) | Institute of Hematology & Blood Diseases Hospital, China | 2020-06-01 |
Track CEBPA Double Mutation automatically
Every clearance here is in the API, with alerts when new ones post.